Wednesday, March 25, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Analysis

Zions Bancorporation: A Stock Poised for Growth?

Andreas Sommer by Andreas Sommer
November 28, 2025
in Analysis, Banking & Insurance, Earnings
0
Zions Bancorporation NA Stock
0
SHARES
34
VIEWS
Share on FacebookShare on Twitter

Zions Bancorporation (ZION) finds itself at a compelling crossroads, navigating a landscape marked by significant institutional investment, an improved credit outlook, and quarterly results that present both strengths and challenges. Currently trading at $53.23, the bank boasts a market capitalization of $7.86 billion.

A Vote of Confidence from Major Investors

Institutional investors are demonstrating strong belief in Zions’ prospects. The second quarter saw substantial activity, with Carlson Capital acquiring 10,800 shares valued at $561,000. An even more significant move came from Prudential Financial, which boosted its position by 15%, adding 39,154 shares to bring its total investment to nearly $16 million. This activity has helped push the total institutional ownership to a notable 76.84%.

Credit Rating Shift to Stable

A key development occurred on November 19th, when S&P Global revised its outlook on Zions from “negative” to “stable,” while simultaneously affirming its BBB+ credit rating. This upgrade underscores the company’s fortified financial position, supported by several key metrics:

  • A solid CET1 capital ratio of 11.3%
  • A Tangible Common Equity ratio that has increased to 6.5%
  • A low level of problem loans, with a non-performing assets ratio of just 0.54%
  • A reduced reliance on brokered deposits, now down to 7.5% of the total

Quarterly Performance: A Tale of Two Quarters

The bank’s recent earnings reports reveal a story of contrasting quarters. Q2 was a period of record performance, driven by a net income of $243 million, translating to earnings per share of $1.63. Net interest income saw a healthy 9% increase to $648 million, and the net interest margin expanded to 3.17%.

Should investors sell immediately? Or is it worth buying Zions Bancorporation NA?

The subsequent third quarter presented a more mixed picture. While pre-provision net revenue grew by 14% and the net interest margin (NIM) improved further to 3.28%, the bank faced headwinds. Total loans declined by 3%, and it had to take a $50 million provision for credit losses tied to two specific commercial loans in California.

Consistent Returns for Shareholders

Amid these operational fluctuations, Zions has maintained its commitment to shareholder returns. The company continues its reliable dividend policy, with a recent quarterly payout of $0.45 per share offering an attractive dividend yield of 3.4%. This payment marks the 13th consecutive year of dividend increases, signaling a long-term commitment to returning value to investors.

Despite these positive indicators, market analysts maintain a cautious stance. The consensus rating currently sits at “Hold,” with an average price target of $61.29. This suggests a potential 15% upside from current levels, but experts appear to be waiting for more consistently positive operational signals before turning more bullish.

Ad

Zions Bancorporation NA Stock: Buy or Sell?! New Zions Bancorporation NA Analysis from March 25 delivers the answer:

The latest Zions Bancorporation NA figures speak for themselves: Urgent action needed for Zions Bancorporation NA investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from March 25.

Zions Bancorporation NA: Buy or sell? Read more here...

Tags: Zions Bancorporation NA
Andreas Sommer

Andreas Sommer

About Andreas Sommer Over 40 years of expertise in market analysis, chart technical analysis, and strategic investment advisory. With more than four decades of experience in banking and financial journalism, Andreas Sommer is recognized as one of the leading analysts in the German-speaking market. His deep understanding of market dynamics and technical analysis has helped countless investors navigate complex financial markets.
Areas of Expertise:
  • Technical Chart Analysis
  • Strategic Investment Advisory
  • Market Trend Analysis
  • Financial Journalism
Andreas brings unparalleled insights from his extensive career in banking and financial markets, making him a trusted voice for investors seeking professional guidance.

Related Posts

Corning Stock
AI & Quantum Computing

Corning’s Strategic Alliance with Meta Fuels Investor Confidence

March 25, 2026
Gossamer Bio Stock
Analysis

Gossamer Bio’s Pivotal FDA Meeting Looms in June 2026

March 25, 2026
Fair Isaac Stock
Analysis

Regulatory Scrutiny and Price Wars Threaten Fair Isaac’s Dominance

March 25, 2026
Next Post
Quantum eMotion Stock

Quantum eMotion Stock Surges on AI Partnership Speculation

CBL & Associates Properties Stock

CBL Properties Faces Critical Holiday Season Test

Fluidigm Stock

Significant Insider Buying Sparks Rally in Standard BioTools Shares

Recommended

Finance_ People trading stocks

Analyst Upgrades QuinStreet Stock to Strong Buy with Increased Price Target

2 years ago
Trimble Stock

Trimble Stock: A Study in Contrasting Signals

7 months ago
Regency Centers Stock

Regency Centers Stock: Strong Dividend Hike Meets Market Skepticism

5 months ago
Cardinal Health Stock

Cardinal Health Shares Test Key Support Level Amid Sector Uncertainty

6 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Bloom Energy Broadcom Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Oracle Palantir PayPal Plug Power QuantumScape Realty Income Robinhood Rocket Lab USA Salesforce Strategy Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

Gossamer Bio’s Pivotal FDA Meeting Looms in June 2026

Semiconductor Sector Faces Supply Chain Strain Amid Helium Shortage Concerns

Regulatory Scrutiny and Price Wars Threaten Fair Isaac’s Dominance

Figma Embraces Third-Party AI to Power Its Design Ecosystem

BioNano Genomics Stock: A Tale of Operational Gains and Revenue Headwinds

Humacyte Shares Hit Record Low Amid Capital Raise and Strategic Shifts

Trending

Coherent Stock
AI & Quantum Computing

Coherent Stock Accelerates Toward New Highs on Key Breakthroughs

by Kennethcix
March 25, 2026
0

Shares of Coherent surged this week, propelled by a landmark technological demonstration and significant corporate developments that...

Corning Stock

Corning’s Strategic Alliance with Meta Fuels Investor Confidence

March 25, 2026
Dell Stock

Dell’s Quantum Security Push Amidst AI-Driven Growth

March 25, 2026
Gossamer Bio Stock

Gossamer Bio’s Pivotal FDA Meeting Looms in June 2026

March 25, 2026
SOXX ETF Stock

Semiconductor Sector Faces Supply Chain Strain Amid Helium Shortage Concerns

March 25, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Coherent Stock Accelerates Toward New Highs on Key Breakthroughs
  • Corning’s Strategic Alliance with Meta Fuels Investor Confidence
  • Dell’s Quantum Security Push Amidst AI-Driven Growth

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com